Cargando…
Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19
OBJECTIVES: Our centre offers a fast-track assessment service for patients with suspected GCA and this service continued to operate during the coronavirus disease 2019 (COVID-19) pandemic. During and immediately following the peak of the COVID-19 pandemic in the UK we observed an increase in the num...
Autores principales: | Luther, Rosamond, Skeoch, Sarah, Pauling, John D, Curd, Christopher, Woodgate, Felicity, Tansley, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749786/ https://www.ncbi.nlm.nih.gov/pubmed/33364547 http://dx.doi.org/10.1093/rap/rkaa067 |
Ejemplares similares
-
Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
por: Mulhearn, Ben, et al.
Publicado: (2023) -
Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020) -
Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020) -
Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022) -
The relationship between glycated haemoglobin levels and the risk of giant cell arteritis – a case–control study
por: Mukhtyar, Chetan, et al.
Publicado: (2020)